Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...
Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...